Exhibit 99.2
![]() |
Q3 2026
Management Report
November 5, 2026

![]() |
Contents
■ Q3 2026 Results
– Overview
– Key Financial & Operating Metrics
– Revenue by Geographic Area
■ Q3 2026 Non-GAAP Results
– Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income
– Reconciliation of GAAP to Non-GAAP Spending by Function
■ Related Information
The following commentary is provided by management and should be referenced in conjunction with PDF Solutions’ Third Quarter 2026 financial results press release available on its Investor Relations website at http://www.pdf.com/financial-news. These remarks represent management’s current views of the Company’s financial and operational performance and are provided to give investors and analysts further insight into its performance in advance of the earnings call webcast. The Company disclaims any duty to update this information for future events.

![]() |
PDF Solutions Reports Third Quarter 2026 Results
|
Q3 2026 Key Metrics |
FINANCIAL RESULTS SUMMARY |
|
|
Total Revenues: $68.3M |
■ Q3 2026 Total revenues of $68.3M was up 11% over Q2 2026, and up 20% over Q3 2025
■ Q3 2026 Platform revenue of $58.3M was up 19% over Q2 2026, and up 22% over Q3 2025
■ Q3 2026 Volume-based revenue of $10.0M was down 19% from Q2 2026, and up 10% over Q3 2025
■ Q3 2026 Recurring revenue was 88%, Q2 2026 was 80%, and Q3 2025 was 95%
■ Q3 2026 Upfront revenue was 12%, Q2 2026 was 20%, and Q3 2025 was 5% |
|
| GAAP Gross Margin: 73% | ||
|
Non-GAAP Gross Margin: 77% |
||
| GAAP Operating Margin: 12% | ||
| Non-GAAP Operating Margin: 28% | ||
|
GAAP Diluted EPS: $0.16 |
||
|
Non-GAAP Diluted EPS: $0.40 |
||
|
Operating Cash Flow: $13.8M |
||
|
Cash Used for Capital Expenditures: $15.1M |
||

![]() |
Key Financial & Operating Metrics
Quarterly
(in thousands, except outstanding shares, which are in millions, and percentages)
|
Q3’26 |
Q2’26 |
Q1’26 |
Q4’25 |
Q3’25 |
||||||
|
Revenues |
$68,334 | $61,529 | $60,130 | $62,403 | $57,115 | |||||
|
GAAP Gross Margin |
73 | % | 69 | % | 72 | % | 73 | % | 72 | % |
|
Non-GAAP Gross Margin |
77 | % | 73 | % | 76 | % | 77 | % | 76 | % |
|
GAAP Operating Margin |
12 | % | 8 | % | 10 | % | 6 | % | 8 | % |
|
Non-GAAP Operating Margin |
28 | % | 22 | % | 25 | % | 24 | % | 23 | % |
|
Outstanding Debt Principal |
$66,250 | $67,500 | $67,500 | $68,125 | $68,750 | |||||
|
Operating Cash Flow |
$13,759 | $16,401 | $1,674 | $17,341 | $3,287 | |||||
|
Cash Used for Capital Expenditures (CAPEX) |
$15,071 | $14,082 | $10,500 | $9,791 | $6,325 | |||||
|
$ Shares Repurchased |
$— | $— | $— | $— | $244 | |||||
|
Weighted Average Common Shares Outstanding |
42.2 | 40.9 | 39.9 | 39.5 | 39.5 | |||||
|
Effective Tax Rate |
18 | % | 8 | % | 18 | % | 102 | % | 63 | % |

![]() |
|
Nine Months Ended September 30, |
|||||||||
|
2026 |
2025 |
2024 |
|||||||
|
Revenues |
$189,993 | $156,621 | $129,380 | ||||||
|
GAAP Gross Margin |
71 | % | 72 | % | 70 | % | |||
|
Non-GAAP Gross Margin |
75 | % | 76 | % | 75 | % | |||
|
GAAP Operating Margin |
10 | % | 2 | % | <1% | ||||
|
Non-GAAP Operating Margin |
25 | % | 20 | % | 17 | % | |||
|
Outstanding Debt Principal |
$66,250 | $68,750 | $— | ||||||
|
Operating Cash Flow |
$31,834 | $6,712 | $8,097 | ||||||
|
Cash Used for CAPEX |
$39,653 | $23,054 | $11,938 | ||||||
|
$ Shares Repurchased |
$— | $244 | $6,899 | ||||||
|
Weighted Average Common Shares Outstanding |
41.0 | 39.2 | 38.5 | ||||||
|
Effective Tax Rate |
15 | % | 205 | % | 31 | % | |||

![]() |
|
Revenue by Geographic Area
|
(Dollars in thousands)
|
Q3’26 |
Q2’26 |
Q1’26 |
Q4’25 |
Q3’25 |
|||||||||||
|
United States |
$22,702 | $34,036 | $24,507 | $36,439 | $30,143 | ||||||||||
|
% of Total |
33 | % | 55 | % | 41 | % | 58 | % | 53 | % | |||||
|
Japan |
$21,655 | $6,563 | $8,679 | $8,156 | $10,091 | ||||||||||
|
% of Total |
32 | % | 11 | % | 14 | % | 13 | % | 18 | % | |||||
|
China |
$11,068 | $8,723 | $8,514 | $7,866 | $5,842 | ||||||||||
|
% of Total |
16 | % | 14 | % | 14 | % | 12 | % | 10 | % | |||||
|
Rest of the world |
$12,909 | $12,207 | $18,430 | $9,942 | $11,039 | ||||||||||
|
% of Total |
19 | % | 20 | % | 31 | % | 17 | % | 19 | % | |||||
|
Total revenues |
$68,334 | $61,529 | $60,130 | $62,403 | $57,115 |

![]() |
|
Revenue by Geographic Area
|
|
Nine Months Ended September 30, |
|||||||||
|
2026 |
2025 |
2024 |
|||||||
|
United States |
$81,245 | $68,325 | $58,021 | ||||||
|
% of Total |
43 | % | 43 | % | 45 | % | |||
|
Japan |
$36,897 | $31,131 | $25,495 | ||||||
|
% of Total |
19 | % | 20 | % | 20 | % | |||
|
China |
$28,305 | $26,075 | $17,526 | ||||||
|
% of Total |
15 | % | 17 | % | 14 | % | |||
|
Rest of the world |
$43,546 | $31,090 | $28,338 | ||||||
|
% of Total |
23 | % | 20 | % | 21 | % | |||
|
Total revenues |
$189,993 | $156,621 | $129,380 | ||||||

![]() |
| GAAP / Non-GAAP Presentation |
In addition to providing results that are determined in accordance with accounting principles generally accepted in the United States of America (“GAAP”), the Company also provides certain non-GAAP financial measures. Non-GAAP gross profit and margin exclude stock-based compensation expense and the amortization of acquired technology under costs of revenues. Non-GAAP income from operations and operating margin exclude stock-based compensation expense, amortization of acquired intangible assets, and the effects of certain non-recurring items, such as expenses for certain legal proceedings, and acquisition-related and integration costs. Non-GAAP net income excludes stock-based compensation expense, amortization of acquired intangible assets, amortization of debt issuance costs, and the effects of certain non-recurring items, such as expenses for certain legal proceedings, acquisition-related and integration costs, recovery from previously written-off property and equipment, and their related income tax effects, as applicable, as well as adjustments for the valuation allowance for deferred tax assets and reconciling items. PDF Solutions management uses non-GAAP financial measures to evaluate the Company’s operating performance and make strategic decisions because these measures exclude items that management believes are not indicative of ongoing operating results and that can vary significantly between periods. These non-GAAP results should not be considered an alternative to, or a substitute for, GAAP financial information, and may differ from similarly titled non-GAAP measures used by other companies. In particular, these non-GAAP financial measures are not a substitute for GAAP measures of income or loss as a measure of performance, or to cash flows from operating, investing and financing activities as a measure of liquidity. A reconciliation of the comparable GAAP financial measures to the non-GAAP financial measures is included herein.

![]() |
|
Reconciliation of GAAP Gross Profit and Margin to
Non-GAAP Gross Profit and Margin
|
Quarterly
(Dollars in thousands)
|
Q3’26 |
Q2’26 |
Q1’26 |
Q4’25 |
Q3’25 |
||||||||||||||||
|
GAAP |
||||||||||||||||||||
|
Total revenues |
$ | 68,334 | $ | 61,529 | $ | 60,130 | $ | 62,403 | $ | 57,115 | ||||||||||
|
Costs of revenues |
18,593 | 19,107 | 16,938 | 16,942 | 15,840 | |||||||||||||||
|
GAAP gross profit |
$ | 49,741 | $ | 42,422 | $ | 43,192 | $ | 45,461 | $ | 41,275 | ||||||||||
|
GAAP gross margin |
73 | % | 69 | % | 72 | % | 73 | % | 72 | % | ||||||||||
|
Non-GAAP |
||||||||||||||||||||
|
GAAP gross profit |
$ | 49,741 | $ | 42,422 | $ | 43,192 | $ | 45,461 | $ | 41,275 | ||||||||||
|
Adjustments to reconcile GAAP to non-GAAP gross profit: |
||||||||||||||||||||
|
Stock-based compensation expense |
1,593 | 1,258 | 1,279 | 1,379 | 1,274 | |||||||||||||||
|
Amortization of acquired technology under costs of revenues |
958 | 998 | 998 | 998 | 998 | |||||||||||||||
|
Non-GAAP gross profit |
$ | 52,292 | $ | 44,678 | $ | 45,469 | $ | 47,838 | $ | 43,547 | ||||||||||
|
Non-GAAP gross margin |
77 | % | 73 | % | 76 | % | 77 | % | 76 | % | ||||||||||

![]() |
|
Reconciliation of GAAP Gross Profit and Margin to
Non-GAAP Gross Profit and Margin
|
Year to Date
(Dollars in thousands)
|
Nine Months Ended September 30, |
||||||||||||
|
2026 |
2025 |
2024 |
||||||||||
|
GAAP |
||||||||||||
|
Total revenues |
$ | 189,993 | $ | 156,621 | $ | 129,380 | ||||||
|
Costs of revenues |
54,638 | 43,681 | 38,243 | |||||||||
|
GAAP gross profit |
$ | 135,355 | $ | 112,940 | $ | 91,137 | ||||||
|
GAAP gross margin |
71 | % | 72 | % | 70 | % | ||||||
|
Non-GAAP |
||||||||||||
|
GAAP gross profit |
$ | 135,355 | $ | 112,940 | $ | 91,137 | ||||||
|
Adjustments to reconcile GAAP to non-GAAP gross profit: |
||||||||||||
|
Stock-based compensation expense |
4,130 | 3,873 | 3,751 | |||||||||
|
Amortization of acquired technology under costs of revenues |
2,954 | 2,674 | 1,752 | |||||||||
|
Non-GAAP gross profit |
$ | 142,439 | $ | 119,487 | $ | 96,640 | ||||||
|
Non-GAAP gross margin |
75 | % | 76 | % | 75 | % | ||||||

![]() |
|
Reconciliation of GAAP Income from Operations and Operating Margin to
Non-GAAP Income from Operations and Operating Margin
|
Quarterly
(Dollars in thousands)
|
Q3’26 |
Q2’26 |
Q1’26 |
Q4’25 |
Q3’25 |
||||||||||||||||
|
GAAP income from operations |
$ | 8,286 | $ | 5,064 | $ | 6,313 | $ | 3,458 | $ | 4,827 | ||||||||||
|
GAAP operating margin |
12 | % | 8 | % | 10 | % | 6 | % | 8 | % | ||||||||||
|
Adjustments to reconcile GAAP to non-GAAP income from operations: |
||||||||||||||||||||
|
Stock-based compensation expense |
$ | 8,472 | $ | 5,998 | $ | 6,396 | $ | 6,866 | $ | 6,264 | ||||||||||
|
Amortization of acquired intangible assets |
1,998 | 2,056 | 2,057 | 2,066 | 2,067 | |||||||||||||||
|
Expenses for certain legal proceedings (1) |
436 | 501 | 210 | 2,574 | 170 | |||||||||||||||
|
Acquisition-related and integration costs |
30 | 30 | 8 | 2 | 22 | |||||||||||||||
|
Non-GAAP income from operations |
$ | 19,222 | $ | 13,649 | $ | 14,984 | $ | 14,966 | $ | 13,350 | ||||||||||
|
Non-GAAP operating margin |
28 | % | 22 | % | 25 | % | 24 | % | 23 | % | ||||||||||
|
(1) |
Represents legal costs and expenses related mainly to a certain arbitration proceeding, which are expected to continue until this matter is fully resolved. |

![]() |
|
Reconciliation of GAAP Income from Operations and Operating Margin to
Non-GAAP Income from Operations and Operating Margin
|
Year to Date
(Dollars in thousands)
|
Nine Months Ended September 30, |
||||||||||||
|
2026 |
2025 |
2024 |
||||||||||
|
GAAP income from operations |
$ | 19,663 | $ | 2,389 | $ | 423 | ||||||
|
GAAP operating margin |
10 | % | 2 | % |
<1% |
|||||||
|
Adjustments to reconcile GAAP to non-GAAP income from operations: |
||||||||||||
|
Stock-based compensation expense |
$ | 20,866 | $ | 19,059 | $ | 18,540 | ||||||
|
Amortization of acquired intangible assets |
6,111 | 5,189 | 2,466 | |||||||||
|
Expenses for certain legal proceedings (1) |
1,147 | 397 | — | |||||||||
|
Acquisition-related and integration costs |
68 | 4,526 | — | |||||||||
|
Non-GAAP income from operations |
$ | 47,855 | $ | 31,560 | $ | 21,429 | ||||||
|
Non-GAAP operating margin |
25 | % | 20 | % | 17 | % | ||||||
|
(1) |
Represents legal costs and expenses related mainly to a certain arbitration proceeding, which are expected to continue until this matter is fully resolved. |

![]() |
| Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income |
Quarterly
(in thousands, except for per share amounts)
|
Q3’26 |
Q2’26 |
Q1’26 |
Q4’25 |
Q3’25 |
|||||||||||
|
GAAP net income (loss) |
$6,841 | $4,271 | $4,791 | $(48 | ) | $1,294 | |||||||||
|
Adjustments to reconcile GAAP net income (loss) to non-GAAP net income: |
|||||||||||||||
|
Stock-based compensation expense |
8,472 | 5,998 | 6,396 | 6,866 | 6,264 | ||||||||||
|
Amortization of acquired intangible assets |
1,998 | 2,056 | 2,057 | 2,066 | 2,067 | ||||||||||
|
Expenses for certain legal proceedings (1) |
436 | 501 | 210 | 2,574 | 170 | ||||||||||
|
Acquisition-related and integration costs |
30 | 30 | 8 | 2 | 22 | ||||||||||
|
Amortization of debt issuance costs |
64 | 60 | 65 | 55 | 54 | ||||||||||
|
Tax impact of valuation allowance for deferred tax assets and reconciling items (2) |
(680 | ) | (1,544 | ) | (878 | ) | 495 | (66 | ) | ||||||
|
Non-GAAP net income |
$17,161 | $11,372 | $12,649 | $12,010 | $9,805 | ||||||||||
|
GAAP net income (loss) per diluted share |
$0.16 | $0.10 | $0.12 | $(0.00 | ) | $0.03 | |||||||||
|
Non-GAAP net income per diluted share |
$0.40 | $0.27 | $0.31 | $0.30 | $0.25 | ||||||||||
|
Weighted average common shares used in GAAP net income (loss) per diluted share calculation |
42,976 | 41,776 | 40,377 | 39,524 | 39,619 | ||||||||||
|
Weighted average common shares used in Non-GAAP net income per diluted share calculation |
42,976 | 41,776 | 40,377 | 39,911 | 39,619 |
|
(1) |
Represents legal costs and expenses related mainly to a certain arbitration proceeding, which are expected to continue until this matter is fully resolved. |
| (2) | The difference between the GAAP and non-GAAP income tax provisions is primarily due to the valuation allowance on a GAAP basis and non-GAAP adjustments. For example, on a GAAP basis, the Company does not receive a deferred tax benefit for foreign tax credits or research and development credits after the valuation allowance. The Company’s non-GAAP tax rate and resulting non-GAAP tax expense is not calculated with a full U.S. federal or state valuation allowance due to the Company’s cumulative non-GAAP income and management’s conclusion that it is more likely than not to utilize its net deferred tax assets (DTAs). Each reporting period, management evaluates the need for a valuation allowance and may place a valuation allowance against its U.S. net DTAs on a non-GAAP basis if it concludes it is more likely than not that it will not be able to utilize some or all of its U.S. DTAs on a non-GAAP basis. |

![]() |
|
Reconciliation of GAAP Net Income (Loss) to Non-GAAP Net Income
|
Year to Date
(in thousands, except for per share amounts)
|
Nine Months Ended September 30, |
||||||
|
2026 |
2025 |
2024 |
||||
|
GAAP net income (loss) |
$15,903 | $(592 | ) | $3,518 | ||
|
Adjustments to reconcile GAAP net income (loss) to non-GAAP net income: |
||||||
|
Stock-based compensation expense |
20,866 | 19,059 | 18,540 | |||
|
Amortization of acquired intangible assets |
6,111 | 5,189 | 2,466 | |||
|
Expenses for certain legal proceedings (1) |
1,147 | 397 | — | |||
|
Acquisition-related and integration costs |
68 | 4,526 | — | |||
|
Recovery from previously written-off property and equipment |
— | (663 | ) | (55 | ) | |
|
Amortization of debt issuance costs |
189 | 130 | — | |||
|
Tax impact of valuation allowance for deferred tax assets and reconciling items (2) |
(3,102 | ) | (2,825 | ) | (1,710 | ) |
|
Non-GAAP net income |
$41,182 | $25,221 | $22,759 | |||
|
GAAP net income (loss) per diluted share |
$0.38 | $(0.02 | ) | $0.09 | ||
|
Non-GAAP net income per diluted share |
$0.99 | $0.64 | $0.58 | |||
|
Weighted average common shares used in GAAP net income (loss) per diluted share calculation |
41,718 | 39,247 | 39,028 | |||
|
Weighted average common shares used in Non-GAAP net income per diluted share calculation |
41,718 | 39,390 | 39,028 | |||
|
(1) |
Represents legal costs and expenses related mainly to a certain arbitration proceeding, which are expected to continue until this matter is fully resolved. |
| (2) | The difference between the GAAP and non-GAAP income tax provisions is primarily due to the valuation allowance on a GAAP basis and non-GAAP adjustments. For example, on a GAAP basis, the Company does not receive a deferred tax benefit for foreign tax credits or research and development credits after the valuation allowance. The Company’s non-GAAP tax rate and resulting non-GAAP tax expense is not calculated with a full U.S. federal or state valuation allowance due to the Company’s cumulative non-GAAP income and management’s conclusion that it is more likely than not to utilize its net deferred tax assets (DTAs). Each reporting period, management evaluates the need for a valuation allowance and may place a valuation allowance against its U.S. net DTAs on a non-GAAP basis if it concludes it is more likely than not that it will not be able to utilize some or all of its U.S. DTAs on a non-GAAP basis. |

![]() |
| Reconciliation of GAAP to Non-GAAP Spending by Function |
Quarterly
(in thousands)
|
Q3’26 |
Q2’26 |
Q1’26 |
Q4’25 |
Q3’25 |
||||||
|
Cost of Revenue - GAAP |
$18,593 | $19,107 | $16,938 | $16,942 | $15,840 | |||||
|
Adjustments to reconcile GAAP Cost of Revenue to Non-GAAP Cost of Revenue: |
||||||||||
|
Stock-based compensation expense |
(1,593 | ) | (1,258 | ) | (1,279 | ) | (1,379 | ) | (1,274 | ) |
|
Amortization of acquired technology |
(958 | ) | (998 | ) | (998 | ) | (998 | ) | (998 | ) |
|
Cost of Revenue - Non-GAAP |
$16,042 | $16,851 | $14,661 | $14,565 | $13,568 | |||||
|
Research & Development - GAAP |
$19,446 | $17,316 | $18,328 | $19,258 | $15,435 | |||||
|
Adjustments to reconcile GAAP R&D to Non-GAAP R&D: |
||||||||||
|
Stock-based compensation expense |
(3,173 | ) | (2,169 | ) | (2,392 | ) | (2,586 | ) | (2,204 | ) |
|
Research & Development - Non-GAAP |
$16,273 | $15,147 | $15,936 | $16,672 | $13,231 | |||||
|
Selling, General, & Administrative - GAAP |
$20,969 | $18,984 | $17,492 | $21,676 | $19,944 | |||||
|
Adjustment to reconcile GAAP SG&A to Non-GAAP SG&A: |
||||||||||
|
Stock-based compensation expense |
(3,706 | ) | (2,571 | ) | (2,725 | ) | (2,901 | ) | (2,786 | ) |
|
Expenses for certain legal proceedings (1) |
(436 | ) | (501 | ) | (210 | ) | (2,574 | ) | (170 | ) |
|
Acquisition-related and integration costs |
(30 | ) | (30 | ) | (8 | ) | (2 | ) | (22 | ) |
|
Selling, General, & Administrative - Non-GAAP |
$16,797 | $15,882 | $14,549 | $16,199 | $16,966 |
|
(1) |
Represents legal costs and expenses related mainly to a certain arbitration proceeding, which are expected to continue until this matter is fully resolved. |

![]() |
|
Reconciliation of GAAP to Non-GAAP Spending by Function
|
Year to Date
(in thousands)
|
Nine Months Ended September 30, |
|||||||||
|
2026 |
2025 |
2024 |
|||||||
|
Cost of Revenue - GAAP |
$54,638 | $43,681 | $38,243 | ||||||
|
Adjustments to reconcile GAAP Cost of Revenue to Non-GAAP Cost of Revenue: |
|||||||||
|
Stock-based compensation expense |
(4,130 | ) | (3,873 | ) | (3,751 | ) | |||
|
Amortization of acquired technology |
(2,954 | ) | (2,674 | ) | (1,752 | ) | |||
|
Cost of Revenue - Non-GAAP |
$47,554 | $37,135 | $32,740 | ||||||
|
Research & Development - GAAP |
$55,090 | $44,976 | $39,149 | ||||||
|
Adjustments to reconcile GAAP R&D to Non-GAAP R&D: |
|||||||||
|
Stock-based compensation expense |
(7,734 | ) | (6,874 | ) | (6,640 | ) | |||
|
Research & Development - Non-GAAP |
$47,356 | $38,102 | $32,509 | ||||||
|
Selling, General, & Administrative - GAAP |
$57,445 | $63,060 | $50,851 | ||||||
|
Adjustment to reconcile GAAP SG&A to Non-GAAP SG&A: |
|||||||||
|
Stock-based compensation expense |
(9,002 | ) | (8,312 | ) | (8,149 | ) | |||
|
Expenses for certain legal proceedings (1) |
(1,147 | ) | (397 | ) | — | ||||
|
Acquisition-related and integration costs |
(68 | ) | (4,526 | ) | — | ||||
|
Selling, General, & Administrative - Non-GAAP |
$47,228 | $49,825 | $42,702 | ||||||
|
(1) |
Represents legal costs and expenses related mainly to a certain arbitration proceeding, which are expected to continue until this matter is fully resolved. |
